Jacques, C.;                     Marchand, F.;                     Chatelais, M.;                     Brulefert, A.;                     Floris, I.    
        Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients. Life 2024, 14, 102.
    https://doi.org/10.3390/life14010102
    AMA Style
    
                                Jacques C,                                 Marchand F,                                 Chatelais M,                                 Brulefert A,                                 Floris I.        
                Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients. Life. 2024; 14(1):102.
        https://doi.org/10.3390/life14010102
    
    Chicago/Turabian Style
    
                                Jacques, Camille,                                 Flora Marchand,                                 Mathias Chatelais,                                 Adrien Brulefert,                                 and Ilaria Floris.        
                2024. "Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients" Life 14, no. 1: 102.
        https://doi.org/10.3390/life14010102
    
    APA Style
    
                                Jacques, C.,                                 Marchand, F.,                                 Chatelais, M.,                                 Brulefert, A.,                                 & Floris, I.        
        
        (2024). Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients. Life, 14(1), 102.
        https://doi.org/10.3390/life14010102